Cumberland Pharmaceuticals Company Profile (NASDAQ:CPIX)

About Cumberland Pharmaceuticals (NASDAQ:CPIX)

Cumberland Pharmaceuticals logoCumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Generic Pharmaceuticals
  • Sub-Industry: Pharmaceuticals
  • Symbol: NASDAQ:CPIX
  • CUSIP: 23077010
  • Web: www.cumberlandpharma.com
Capitalization:
  • Market Cap: $114.45 million
  • Outstanding Shares: 15,896,000
Average Prices:
  • 50 Day Moving Avg: $6.85
  • 200 Day Moving Avg: $6.68
  • 52 Week Range: $4.60 - $7.49
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 80.00
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $36.18 million
  • Price / Sales: 3.16
  • Book Value: $4.18 per share
  • Price / Book: 1.72
Profitability:
  • EBIDTA: ($626,147.00)
  • Net Margins: -19.57%
  • Return on Equity: -0.13%
  • Return on Assets: -0.11%
Debt:
  • Debt-to-Equity Ratio: 0.10%
  • Current Ratio: 4.88%
  • Quick Ratio: 4.45%
Misc:
  • Average Volume: 16,423 shs.
  • Beta: 0.97
  • Short Ratio: 4.88
 

Frequently Asked Questions for Cumberland Pharmaceuticals (NASDAQ:CPIX)

What is Cumberland Pharmaceuticals' stock symbol?

Cumberland Pharmaceuticals trades on the NASDAQ under the ticker symbol "CPIX."

How were Cumberland Pharmaceuticals' earnings last quarter?

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) released its quarterly earnings data on Tuesday, August, 8th. The company reported ($0.07) earnings per share (EPS) for the quarter. The business had revenue of $8.67 million for the quarter. Cumberland Pharmaceuticals had a negative return on equity of 0.13% and a negative net margin of 19.57%. View Cumberland Pharmaceuticals' Earnings History.

When will Cumberland Pharmaceuticals make its next earnings announcement?

Cumberland Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, November, 7th 2017. View Earnings Estimates for Cumberland Pharmaceuticals.

Who are some of Cumberland Pharmaceuticals' key competitors?

Who are Cumberland Pharmaceuticals' key executives?

Cumberland Pharmaceuticals' management team includes the folowing people:

  • A. J. Kazimi, Chairman of the Board, Principal Executive Officer
  • Michael Bonner, Senior Director Finance and Accounting and Chief Financial Officer
  • Martin E. Cearnal, Senior Vice President, Chief Commercial Officer, Director
  • Leo Pavliv, Senior Vice President - Operations, Chief Development Officer
  • James L. Herman, Vice President - National Accounts, Chief Compliance Officer
  • Amy Dix Rock Ph.D., Vice President - Regulatory & Scientific Affairs
  • Gordon R. Bernard M.D., Independent Director
  • Jonathan Griggs, Independent Director
  • Joey A. Jacobs, Independent Director
  • James R Jones, Independent Director

Who owns Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock is owned by many different of institutional and retail investors. Top institutional investors include Stonepine Capital Management LLC (6.92%), Dimensional Fund Advisors LP (5.40%), Vanguard Group Inc. (1.86%), New York State Common Retirement Fund (1.68%), JW Asset Management LLC (1.65%) and Acadian Asset Management LLC (0.81%). Company insiders that own Cumberland Pharmaceuticals stock include Michael Bonner and Thomas R Lawrence. View Institutional Ownership Trends for Cumberland Pharmaceuticals.

Who sold Cumberland Pharmaceuticals stock? Who is selling Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Spark Investment Management LLC, Acadian Asset Management LLC and Bard Associates Inc.. View Insider Buying and Selling for Cumberland Pharmaceuticals.

Who bought Cumberland Pharmaceuticals stock? Who is buying Cumberland Pharmaceuticals stock?

Cumberland Pharmaceuticals' stock was purchased by a variety of institutional investors in the last quarter, including Stonepine Capital Management LLC, Essex Investment Management Co. LLC, Dimensional Fund Advisors LP, Vanguard Group Inc. and Ameriprise Financial Inc.. View Insider Buying and Selling for Cumberland Pharmaceuticals.

How do I buy Cumberland Pharmaceuticals stock?

Shares of Cumberland Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cumberland Pharmaceuticals' stock price today?

One share of Cumberland Pharmaceuticals stock can currently be purchased for approximately $7.20.


MarketBeat Community Rating for Cumberland Pharmaceuticals (NASDAQ CPIX)
Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  46 (Vote Underperform)
Total Votes:  78
MarketBeat's community ratings are surveys of what our community members think about Cumberland Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cumberland Pharmaceuticals (NASDAQ:CPIX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Earnings by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Earnings History by Quarter for Cumberland Pharmaceuticals (NASDAQ CPIX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/30/2017N/AView Earnings Details
8/8/2017Q2 2017($0.07)$8.67 millionViewListenView Earnings Details
5/15/2017Q1 2017($0.08)$9.64 millionViewN/AView Earnings Details
3/7/2017Q4 2016$0.05$9.08 millionViewListenView Earnings Details
11/1/2016Q316$0.01$7.90 million$8.80 millionViewN/AView Earnings Details
5/10/2016Q116$0.02$8.70 million$7.70 millionViewListenView Earnings Details
5/7/2015Q115$0.09$8.10 million$8.70 millionViewN/AView Earnings Details
5/13/2014Q114$0.02$10.26 million$8.09 millionViewN/AView Earnings Details
3/4/2014Q4 13$0.05($0.08)ViewN/AView Earnings Details
11/5/2013Q313($0.04)$7.60 million$6.50 millionViewN/AView Earnings Details
8/6/2013Q2 2013$0.02($0.03)$9.40 million$7.10 millionViewN/AView Earnings Details
5/2/2013Q113$0.05$0.05$10.00 million$10.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$0.14$0.09$13.87 million$13.70 millionViewN/AView Earnings Details
11/1/2012Q312$0.09$0.10$13.05 million$12.50 millionViewN/AView Earnings Details
8/2/2012$0.07$0.09ViewN/AView Earnings Details
5/3/2012$0.05$0.02ViewN/AView Earnings Details
2/29/2012$0.05$0.04ViewN/AView Earnings Details
11/3/2011$0.06$0.09ViewN/AView Earnings Details
8/4/2011$0.04$0.11ViewN/AView Earnings Details
5/5/2011$0.03$0.03ViewN/AView Earnings Details
3/8/2011$0.03$0.04ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Current Year EPS Consensus Estimate: $0.09 EPS
Next Year EPS Consensus Estimate: $0.09 EPS

Dividends

Dividend History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Insider Ownership Percentage: 38.00%
Institutional Ownership Percentage: 34.30%
Insider Trades by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Institutional Ownership by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Insider Trades by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/23/2017Michael BonnerCFOBuy500$6.72$3,360.00View SEC Filing  
5/31/2017Michael BonnerCFOBuy300$6.95$2,085.00View SEC Filing  
4/7/2017Thomas R. LawrenceDirectorSell6,000$6.40$38,400.00View SEC Filing  
3/23/2017Michael BonnerCFOBuy900$6.42$5,778.00View SEC Filing  
11/17/2016Michael BonnerCFOBuy900$5.50$4,950.00View SEC Filing  
8/17/2016Thomas R LawrenceDirectorSell3,000$4.60$13,800.00View SEC Filing  
5/26/2016Thomas R LawrenceDirectorSell3,000$4.55$13,650.00View SEC Filing  
11/19/2015Thomas R LawrenceDirectorSell4,000$5.61$22,440.00View SEC Filing  
3/19/2015Thomas R LawrenceDirectorSell6,000$6.95$41,700.00View SEC Filing  
11/20/2014Thomas R LawrenceDirectorSell10,000$5.12$51,200.00View SEC Filing  
8/21/2014Thomas R LawrenceDirectorSell15,000$5.08$76,200.00View SEC Filing  
3/19/2014Thomas LawrenceDirectorSell20,000$4.54$90,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Latest Headlines for Cumberland Pharmaceuticals (NASDAQ:CPIX)
Source:
DateHeadline
finance.yahoo.com logoWhat Are The Drivers Of Cumberland Pharmaceuticals Inc’s (CPIX) Risks?
finance.yahoo.com - September 13 at 6:41 PM
finance.yahoo.com logoEdited Transcript of CPIX earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 12 at 3:55 AM
finance.yahoo.com logoCumberland reports 2Q loss
finance.yahoo.com - August 8 at 10:15 PM
americanbankingnews.com logoCumberland Pharmaceuticals Inc. (CPIX) Releases Earnings Results
www.americanbankingnews.com - August 8 at 9:30 PM
finance.yahoo.com logoCumberland Pharmaceutical Reports Double Digit Revenue Growth For The Fourth Consecutive Quarter
finance.yahoo.com - August 8 at 5:13 PM
americanbankingnews.com logoCumberland Pharmaceuticals Inc. (CPIX) Scheduled to Post Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 3 at 10:40 AM
finance.yahoo.com logoCumberland Pharmaceuticals To Announce Second Quarter 2017 Financial Results
finance.yahoo.com - August 1 at 6:08 PM
finance.yahoo.com logoCumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient Support
finance.yahoo.com - July 31 at 5:23 PM
americanbankingnews.com logoCumberland Pharmaceuticals Inc. (CPIX) Set to Announce Earnings on Monday
www.americanbankingnews.com - July 24 at 8:49 AM
americanbankingnews.com logoFinancial Contrast: Cumberland Pharmaceuticals (NASDAQ:CPIX) and Merus Labs International (MSLI)
www.americanbankingnews.com - July 17 at 10:27 AM
finance.yahoo.com logoETFs with exposure to Cumberland Pharmaceuticals, Inc. : July 12, 2017
finance.yahoo.com - July 12 at 6:10 PM
americanbankingnews.com logoHead-To-Head Survey: Cumberland Pharmaceuticals (CPIX) & Merus Labs International (MSLI)
www.americanbankingnews.com - June 22 at 12:20 AM
finance.yahoo.com logoETFs with exposure to Cumberland Pharmaceuticals, Inc. : May 25, 2017
finance.yahoo.com - May 25 at 6:02 PM
finance.yahoo.com logoCumberland Pharmaceuticals, Inc. :CPIX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
finance.yahoo.com - May 24 at 4:18 PM
americanbankingnews.com logoCumberland Pharmaceuticals, Inc. (CPIX) Announces Quarterly Earnings Results
www.americanbankingnews.com - May 16 at 2:20 PM
finance.yahoo.com logoEdited Transcript of CPIX earnings conference call or presentation 15-May-17 8:30pm GMT
finance.yahoo.com - May 16 at 12:16 PM
finance.yahoo.com logoInvestor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call
finance.yahoo.com - May 15 at 4:23 PM
finance.yahoo.com logoInvestor Network: Cumberland Pharmaceuticals Inc. to Host Earnings Call
finance.yahoo.com - May 15 at 4:23 PM
finance.yahoo.com logoCumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017
finance.yahoo.com - May 15 at 4:23 PM
finance.yahoo.com logoCumberland Pharmaceuticals Reports Revenue Growth Of 25% In First Quarter 2017
finance.yahoo.com - May 15 at 4:23 PM
finance.yahoo.com logoCumberland Pharmaceuticals to Announce First Quarter 2017 Financial Results
finance.yahoo.com - May 8 at 4:21 PM
americanbankingnews.com logoCumberland Pharmaceuticals (CPIX) Getting Somewhat Positive News Coverage, AlphaOne Reports
www.americanbankingnews.com - May 1 at 6:28 PM
americanbankingnews.com logoCumberland Pharmaceuticals, Inc. (CPIX) Short Interest Up 26.3% in April
www.americanbankingnews.com - April 29 at 11:56 PM
americanbankingnews.com logoCumberland Pharmaceuticals (CPIX) Given Daily Media Sentiment Rating of 0.36
www.americanbankingnews.com - April 27 at 10:30 AM
finance.yahoo.com logoNew Kristalose® Growth Driver Established Through Co-Promotion Agreement
finance.yahoo.com - April 26 at 5:52 PM
americanbankingnews.com logoCumberland Pharmaceuticals (CPIX) Getting Somewhat Positive Press Coverage, AlphaOne Reports
www.americanbankingnews.com - April 23 at 5:06 PM
americanbankingnews.com logoThomas R. Lawrence Sells 6,000 Shares of Cumberland Pharmaceuticals, Inc. (CPIX) Stock
www.americanbankingnews.com - April 7 at 8:28 PM
streetinsider.com logoCumberland Pharmaceuticals (CPIX) Reports Significant Post Surgical Pain Reduction and Decrease in Opioid Use from Caldolor®
www.streetinsider.com - March 28 at 4:14 PM
finance.yahoo.com logoCaldolor® Demonstrates Significant Post Surgical Pain Reduction and Decrease in Opioid Use
finance.yahoo.com - March 27 at 4:22 PM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial Stateme
biz.yahoo.com - March 22 at 9:35 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc.
finance.yahoo.com - March 22 at 4:35 PM
businesswire.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland ...
www.businesswire.com - March 18 at 1:56 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cumberland Pharmaceuticals Inc.
finance.yahoo.com - March 17 at 3:54 PM
finance.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Financials
finance.yahoo.com - March 16 at 5:49 PM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant
biz.yahoo.com - March 16 at 5:49 PM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
biz.yahoo.com - March 13 at 12:28 PM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - March 10 at 5:32 PM
finance.yahoo.com logoEdited Transcript of CPIX earnings conference call or presentation 7-Mar-17 9:30pm GMT
finance.yahoo.com - March 8 at 5:12 PM
finance.yahoo.com logoCumberland Pharmaceuticals Reports Fourth Quarter And Full Year 2016 Financial Results
finance.yahoo.com - March 7 at 4:26 PM
biz.yahoo.com logoQ4 2016 Cumberland Pharmaceuticals Inc Earnings Release - After Market Close
biz.yahoo.com - March 7 at 12:16 PM
finance.yahoo.com logoCumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2016 Financial Results
finance.yahoo.com - February 28 at 4:39 PM
prnewswire.com logoCaldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics
www.prnewswire.com - February 7 at 5:35 PM
prnewswire.com logoCaldolor® Pediatric Fever Study Published Supporting Its Efficacy, Safety And Pharmacokinetics
www.prnewswire.com - February 7 at 5:35 PM
us.rd.yahoo.com logoU.S. Court Of Appeals Affirms Cumberland Pharmaceuticals' Victory In Patent Litigation Case
us.rd.yahoo.com - January 30 at 5:19 PM
us.rd.yahoo.com logo8:17 am Cumberland Pharma announces the U.S. Court of Appeals for the Federal Circuit ruled in favor of Cumberland in a patent case associated with its Acetadote product, rejecting Mylan's (MYL) challenge o
us.rd.yahoo.com - January 30 at 5:19 PM
finance.yahoo.com logoCumberland Pharmaceuticals Announces Kenneth J. Krogulski To Join Its Board Of Directors
finance.yahoo.com - January 16 at 10:28 AM
biz.yahoo.com logoCUMBERLAND PHARMACEUTICALS INC Files SEC form 8-K, Other Events
biz.yahoo.com - January 13 at 5:11 PM
streetinsider.com logoCumberland Pharmaceuticals (CPIX), Clinigen Enter Pact for Commercialization of Totect
www.streetinsider.com - January 9 at 10:37 PM
finance.yahoo.com logo9:31 am Cumberland Pharma and and Clinigen Group plc announce an exclusive agreement to commercialize the oncology support drug Totect (dexrazoxane hydrochloride) in the U.S.
finance.yahoo.com - January 9 at 5:37 PM
finance.yahoo.com logoBlog Coverage Cumberland Pharma Bags Exclusive Rights for Europe Based Nordic Group Injectable Methotrexate Product Line for the US Market
finance.yahoo.com - November 17 at 10:16 AM

Social

Chart

Cumberland Pharmaceuticals (CPIX) Chart for Saturday, September, 23, 2017

This page was last updated on 9/23/2017 by MarketBeat.com Staff